The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
This marks the fourth acquisition by Corona Remedies from multinational corporations
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Subscribe To Our Newsletter & Stay Updated
